Statements, 2015

Gavi Board Chair steps down after five years of unparalleled achievement.

Vaccine Alliance support already helping to immunise millions of children in OIC member states.

As the international community marks the seventh World Pneumonia Day, Gavi pneumococcal and pentavalent vaccines are reaching children at an accelerated pace.

SAGE and MPAC call for pilot introductions in three to five settings.

Korean support for immunisation in developing countries now stands at US$ 15 million.

Inclusion of globally recognised indicator vital for measuring impact of SDG3.

China seals commitment to support immunisation in developing countries

Ring vaccination trial data suggests vaccine is highly effective.

Statement from Gavi, the Vaccine Alliance.

Vaccine receives positive scientific opinion.

Gavi highlighted at Addis Ababa meeting.

Funding will cover the costs of vaccines in six countries.

Worryingly low immunisation rates risk further deaths as Ebola recedes.

Leaders reaffirm commitment in health through bilateral and multilateral structures

First time pledge will enable Gavi to reach children with life-saving vaccines.

Support will enhance advocacy efforts across Arab League countries

Funding will help Vaccine Alliance protect millions of children from infectious disease.

Clarification from Gavi, the Vaccine Alliance

Statement from Gavi CEO Dr Seth Berkley

Once-in-a-generation opportunity to improve vaccine access and coverage in developing countries

Latest data published by Glaxosmithkline and PATH Malaria Vaccine initiative includes booster dose results.

Clarification from Gavi, the Vaccine Alliance